TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Rupro AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
56,371
|
83,832
|
58,715 |
Financial expenses |
560
|
458
|
392 |
Earnings before taxes |
-5,341
|
4,922
|
-408 |
Total assets |
24,527
|
36,709
|
27,123 |
Current assets |
17,481
|
30,151
|
19,447 |
Current liabilities |
13,799
|
20,782
|
13,599 |
Equity capital |
5,330
|
9,354
|
6,518 |
- share capital |
1,500
|
1,350
![]() |
1,350 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
21.7%
|
25.5%
|
24.0% |
Turnover per employee | |||
Profit as a percentage of turnover |
-9.5%
|
5.9%
|
-0.7% |
Return on assets (ROA) |
-19.5%
|
14.7%
|
-0.1% |
Current ratio |
126.7%
|
145.1%
|
143.0% |
Return on equity (ROE) |
-100.2%
|
52.6%
|
-6.3% |
Change turnover |
-27,461
|
25,117
|
-477 |
Change turnover % |
-33%
|
43%
|
-1% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.